Original Source(s)
JAK Monotherapy Shows Efficacy in RA Review
-
by Andrea Surnit
May 22, 2026
Related Content
RA Outcomes Improved in KURAMA Cohort
Ten-year observational data showed lower disease activity and functional disability coinciding with broader use of biologic and targeted synthetic therapies.
May 22, 2026
-
4 min
FDA Clears Golimumab Biosimilars
New biosimilars enter the market with pharmacy-level substitution eligibility for rheumatology and gastroenterology indications.
May 18, 2026
-
2 min
Sex Differences Seen in Immune Cells
Single-cell analysis identified sex-biased immune-cell composition, gene expression, and genetic regulation in unstimulated blood immune cells
May 14, 2026
-
4 min
